Seeing Is Believing
Currently out of the existing stock ratings of Alethia Young, 220 are a BUY (80.29%), 54 are a HOLD (19.71%).
Analyst Alethia Young works with a stock forecast success ratio of 53.27% fulfilled within 300.94 days on average. Previously, Alethia Young worked at CANTOR FITZGERALD.
Alethia Young’s has documented 574 price targets and ratings displayed on 47 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 16-Oct-2023.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for BIIB (BIOGEN) at 11/3/2020. The price target of $278 was fulfilled within 1 day with a profit of $30.99 (12.55%) receiving and performance score of 125.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2
$1.82 (1011.11%)
5
5 years 4 days ago
2/3 (66.67%)
$-0.96 (-32.43%)
528
Hold
4
6 years 2 months 29 days ago
4/4 (100%)
$-0.81 (-16.84%)
106
Buy
5
$4.82 (2677.78%)
6
6 years 4 months 26 days ago
0/4 (0%)
$2.14 (74.83%)
Buy
10
6 years 7 months 25 days ago
0/2 (0%)
$5.79 (137.53%)
Hold
4
$3.82 (2122.22%)
5
6 years 7 months 26 days ago
6/7 (85.71%)
$0.17 (4.44%)
49
What Year was the first public recommendation made by Alethia Young?